Navin Fluorine Appoints Vinod Shetty as CHRO

0 min read     Updated on 22 May 2026, 08:49 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Navin Fluorine International Limited has appointed Mr. Vinod Shetty as its Chief Human Resource Officer effective May 21, 2026. He brings nearly three decades of rich and diverse Human Resources experience, including over 16 years in senior leadership roles.

powered bylight_fuzz_icon
40883602

*this image is generated using AI for illustrative purposes only.

Navin Fluorine International Limited has appointed Mr. Vinod Shetty as its Chief Human Resource Officer, effective May 21, 2026. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This appointment follows the previous intimation regarding the resignation of Mr. Pankaj Lochan from the position of Chief Human Resource Officer.

Profile of Mr. Vinod Shetty

Mr. Vinod Shetty brings nearly three decades of rich and diverse Human Resources experience to the role. His career includes over 16 years in senior leadership positions across leading multinational and Indian organizations. He possesses a proven track record in driving organizational transformation and building capabilities that align with organizational growth strategies.

Previous Experience

Prior to joining navin fluorine international , Mr. Shetty served as the Head of India HR & Communications at Teva Pharmaceuticals. He has held significant leadership roles at several other major companies, including Sanofi India, Glenmark Pharmaceuticals, Pfizer India, German Remedies, IPCA Laboratories, and Tata Donnelley Ltd.

Educational Background

Mr. Shetty holds a Master's degree in Human Resources. His professional foundation is strengthened by strong expertise in Labour Laws and Training & Development.

Historical Stock Returns for Navin Fluorine International

1 Day5 Days1 Month6 Months1 Year5 Years
-0.55%+3.65%+4.32%+23.53%+55.28%+116.32%

How might Mr. Shetty's extensive pharmaceutical industry background influence Navin Fluorine's talent acquisition and workforce strategy as the company expands its specialty chemicals and CDMO business?

What organizational transformation initiatives could Mr. Shetty prioritize to support Navin Fluorine's ambitious capacity expansion plans and growing global client base?

Could the leadership transition in the CHRO role signal broader strategic shifts in Navin Fluorine's human capital management approach, particularly in attracting specialized technical talent?

Navin Fluorine International
View Company Insights
View All News
like18
dislike

Navin Fluorine FY26 net profit jumps 130% to ₹663.56 crore

2 min read     Updated on 22 May 2026, 08:27 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Navin Fluorine International Limited reported a 130% YoY rise in FY26 net profit to ₹663.56 crore, supported by a 41% increase in revenue to ₹3,313.90 crore. Q4 FY26 net profit grew 124% to ₹212.62 crore. The company is executing capex plans worth ₹431.5 crore across HFC, Specialty, and Advanced Materials segments.

powered bylight_fuzz_icon
40964238

*this image is generated using AI for illustrative purposes only.

Navin Fluorine International Limited has announced its financial results for the fiscal year ended March 31, 2026, reporting a 130% year-on-year increase in net profit to ₹663.56 crore. The company achieved this growth on the back of a 41% rise in revenue from operations, which reached ₹3,313.90 crore for FY26. The operating EBITDA for the year stood at ₹1,081.68 crore, marking a 103% YoY increase, with the margin expanding to 32.6%.

Financial Performance Overview

The company’s consolidated financial statements highlight robust growth across key metrics. Profit before tax for FY26 grew 130% to ₹873.17 crore. The operating profit before tax (PBT) saw a similar upward trend, increasing 142% to ₹814.63 crore. For the quarter ended March 31, 2026 (Q4 FY26), revenue from operations was ₹937.71 crore, a 34% increase from the corresponding quarter in the previous year. Net profit for Q4 FY26 rose 124% to ₹212.62 crore.

Segment and Operational Growth

Revenue growth was driven by performance across the company’s three primary business verticals: Hydrofluorocarbon Products (HPP), Specialty Chemicals, and Contract Development and Manufacturing Organization (CDMO). The HPP segment reported a 34% revenue growth for FY26, while Specialty Chemicals and CDMO grew 44% and 59% respectively. The company noted that the pricing environment for HFCs remained constructive throughout the year.

Capital Expenditure and Future Outlook

Navin Fluorine International is advancing several capital expenditure projects to support future growth. The company is investing ₹236.5 crore in additional HFC capacity equivalent to 15,000 MTPA of R32, expected to be commissioned by Q3FY27. Another project involving the de-bottlenecking of MPP capacity at Dahej, with a capex of ₹75 crore, is also targeted for commissioning in Q3FY27. Additionally, the company is setting up initial commercial capacity for advanced materials with a capex of ₹120 crore, targeted for Q1FY27.

Consolidated Financial Results (FY26)

Particulars (₹ Crs.) FY26 FY25 YoY Change
Net Revenue from Operations 3,313.90 2,349.38 41%
Operating EBITDA 1,081.68 533.72 103%
Operating EBITDA Margin 32.6% 22.7% 992 Bps
Profit After Tax 663.56 288.60 130%

Corporate Governance and Investor Meet

The company has scheduled an analyst and institutional investor meet on June 02, 2026, as part of the Axis Capital Rising Stars Conference. The interaction will cover discussions based on publicly available information. Navin Fluorine continues to focus on expanding its footprint in emerging and innovative products while maintaining its commitment to environmental, social, and governance (ESG) standards.

Historical Stock Returns for Navin Fluorine International

1 Day5 Days1 Month6 Months1 Year5 Years
-0.55%+3.65%+4.32%+23.53%+55.28%+116.32%

How might the commissioning of 15,000 MTPA additional HFC capacity in Q3FY27 impact Navin Fluorine's market share amid potential global HFC pricing fluctuations?

What are the long-term revenue and margin targets for the advanced materials segment once the ₹120 crore initial commercial capacity goes live in Q1FY27?

Given the 59% CDMO revenue growth in FY26, which therapeutic areas or global pharma partnerships are likely to drive the next phase of CDMO expansion?

Navin Fluorine International
View Company Insights
View All News
like16
dislike

More News on Navin Fluorine International

1 Year Returns:+55.28%